Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.42 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.40 |
| ▸ | MGAM | O43451 | 2/20 | 0.39 |
| ▸ | GAA | P10253 | 2/20 | 0.39 |
| ▸ | SI | P14410 | 2/20 | 0.39 |
| ▸ | MGAM2 | Q2M2H8 | 2/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 2/20 | 0.33 |
| ▸ | CA2 | P00918 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | KIF11 | P52732 | 1/20 | 0.33 |
| ▸ | CA12 | O43570 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL196760 | 1.00 | TSHR (0.42) | TSHRSLC1A1MGAMGAASI | |
| SCHEMBL12286780 | 1.00 | TSHR (0.42) | TSHRSLC1A1MGAMGAASI | |
| Hydrochloric Acid SCHEMBL1802201 | 0.98 | TSHR (0.40) | TSHRSLC1A1MGAMGAASI | |
| Hydrochloric Acid SCHEMBL1802204 | 0.98 | TSHR (0.40) | TSHRSLC1A1MGAMGAASI | |
| Hydrochloric Acid SCHEMBL9538568 | 0.98 | TSHR (0.40) | TSHRSLC1A1MGAMGAASI | |
| Hydrochloric Acid SCHEMBL8968568 | 0.98 | TSHR (0.40) | TSHRSLC1A1MGAMGAASI | |
| Iodide SCHEMBL17393001 | 0.98 | TSHR (0.40) | TSHRSLC1A1MGAMGAASI | |
| Hydrochloric Acid SCHEMBL9538572 | 0.98 | TSHR (0.40) | TSHRSLC1A1MGAMGAASI | |
| SCHEMBL25491243 | 0.90 | SLC1A1 (0.35) | TSHRSLC1A1MGAMGAASI | |
| SCHEMBL25491151 | 0.88 | SMN1; SMN2 (0.36) | TSHRSLC1A1MGAMGAASI |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 619 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122068110-A | Amino acid type supermolecule gel polymer electrolyte and preparation method and application thereof | 四川荣创新能动力系统有限公司 | 2026-05-19 | — | — | CN | claimed |
| CN-119136613-A | Preparation method of perovskite solar cell based on buried bottom modification | 浙大宁波理工学院 | 2024-12-13 | — | — | CN | claimed |
| CN-118078747-A | Dry suspension of crude drug powder and its preparation method | 江苏神猴医药研究有限公司 | 2024-05-28 | — | — | CN | claimed |
| CN-117580593-A | Anthracycline antibody conjugates | 思进公司 | 2024-02-20 | — | — | CN | claimed |
| CN-116847886-A | Immunostimulatory compounds and conjugates | 思进公司 | 2023-10-03 | — | — | CN | claimed |
| CN-114907546-B | Multifunctional polyurea acid ester derivative and preparation method and application thereof | 四川大学 | 2023-06-02 | — | — | CN | claimed |
| CN-115896080-A | Methyl aspartic acid lyase EcMAL mutant and preparation method and application thereof | 华南理工大学 | 2023-04-04 | — | — | CN | claimed |
| CN-115656161-A | Phthalic dicarboxaldehyde disinfectant concentration detection indicator card and preparation method thereof | 利康医药科技江苏有限公司 | 2023-01-31 | — | — | CN | claimed |
| CN-115304516-A | Compounds with unconventional chromophores, their preparation and use | 四川大学 | 2022-11-08 | — | — | CN | claimed |
| CN-114984296-A | Thermally induced hydrogel embolic agent with X-ray developing capability and application thereof | 复旦大学 | 2022-09-02 | — | — | CN | claimed |
| US-20050042198-A1 | Ophthalmic and contact lens wetting solutions | FXS VENTURES, LLC | 2005-02-24 | — | — | US | claimed |
| US-20040220264-A1 | Bioavailability and improved delivery of acidic pharmaceutical drugs | YU RUEY J | 2004-11-04 | — | — | US | claimed |
| WO-2004082628-A2 | IMPROVED BIOAVAILABILITY AND IMPROVED DELIVERY OF ACIDIC PHARMACEUTICAL DRUGS | YU RUEY J (US) | 2004-09-30 | — | — | WO | claimed |
| US-20030190258-A1 | Ophthalmic and contact lens solutions using low molecular weight amines | FXS VENTURES, LLC | 2003-10-09 | — | — | US | claimed |
| US-20030018100-A1 | Inks with sulfonated polyester-amine resins | XEROX CORPORATION. | 2003-01-23 | — | — | US | claimed |
| US-6432601-B1 | DRY TONER INK | XEROX CORPORATION | 2002-08-13 | — | — | US | claimed |
| US-6348561-B1 | COPOLYMER FROM DIOL, DIACID, ALKALI SULFONATED DIACID AND AMINODIACID MONOMERS; TONERS, INKS, DISPERSANTS; HEAT AND COLD RESISTANCE; SHELF LIFE | XEROX CORPORATION | 2002-02-19 | — | — | US | claimed |
| US-4892820-A | Solvent system for enzymatic coupling process | THE NUTRASWEET COMPANY (US) | 1990-01-09 | — | — | US | claimed |
| US-4443475-A | ANTIARRHYTHMIA AGENTS, ANTIDEPRESSANTS | CAVAZZA CLAUDIO (IT) | 1984-04-17 | — | — | US | claimed |
| US-3936469-A | Process for preparing N-carboxylic anhydrides of amino acids | KYOWA HAKKO KOGYO KABUSHIKI KAISHA (JA) | 1976-02-03 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030190258-A1 | Ophthalmic and contact lens solutions using low molecular weight amines | H1-0, ARGLU1, H1-3 | TSHR 384/4885SLC1A1 870/4885MGAM 2297/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.